Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Banu Arun

Showing results (41-50 of 179) with videos related to

Pageof 18
Sort By:
Breast Cancer Research and Treatment|August 25, 2022
Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriersMaryam Nemati Shafaee, Kristina Goutsouliak, Heather Lin, et al.
The Breast Journal|February 8, 2011
Cancer risk management decisions of women with BRCA1 or BRCA2 variants of uncertain significanceKaylene Ready, Angelica M Gutierrez-Barrera, Christopher Amos, et al.
The Breast Journal|June 5, 2020
Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutationsSoley Bayraktar, Jade Z Zhou, Roland Bassett, et al.
Cancer Journal (Sudbury, Mass.)|February 28, 2008
Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapyOzlem Er, Debra K Frye, Shu-Wan C Kau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancerNeslihan Cabioglu, M Sertac Yazici, Banu Arun, et al.
Cancer|June 6, 2024
What do cancer genetic providers want us to know about variant reclassification and recontact that we are not asking? A thematic analysis of open-ended survey responsesKerri Brown, Marisel Ponton, Elenita Davidson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 8, 2017
Targeting Aberrant p70S6K Activation for Estrogen Receptor-Negative Breast Cancer PreventionXiao Wang, Jun Yao, Jinyang Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Evaluating the NCCN Clinical Criteria for Recommending <i>BRCA1</i> and <i>BRCA2</i> Genetic Testing in Patients With Breast CancerCaiqian Cropper, Ashley Woodson, Banu Arun, et al.
Cancer|August 7, 2007
Multifocal breast cancer in women < or =35 years oldJennifer K Litton, Yesim Eralp, Ana M Gonzalez-Angulo, et al.
Journal of Adolescent and Young Adult Oncology|August 25, 2020
Impact of a Genetic Evaluation Initiative to Increase Access to Genetic Services for Adolescent and Young Adults at a Tertiary Cancer HospitalSukh Makhnoon, Jessica Corredor, Banu Arun, et al.
Pageof 18

Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
Breast Cancer Research and Treatment|August 25, 2022
Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriersMaryam Nemati Shafaee, Kristina Goutsouliak, Heather Lin, et al.
The Breast Journal|February 8, 2011
Cancer risk management decisions of women with BRCA1 or BRCA2 variants of uncertain significanceKaylene Ready, Angelica M Gutierrez-Barrera, Christopher Amos, et al.
The Breast Journal|June 5, 2020
Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutationsSoley Bayraktar, Jade Z Zhou, Roland Bassett, et al.
Cancer Journal (Sudbury, Mass.)|February 28, 2008
Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapyOzlem Er, Debra K Frye, Shu-Wan C Kau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancerNeslihan Cabioglu, M Sertac Yazici, Banu Arun, et al.
Cancer|June 6, 2024
What do cancer genetic providers want us to know about variant reclassification and recontact that we are not asking? A thematic analysis of open-ended survey responsesKerri Brown, Marisel Ponton, Elenita Davidson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 8, 2017
Targeting Aberrant p70S6K Activation for Estrogen Receptor-Negative Breast Cancer PreventionXiao Wang, Jun Yao, Jinyang Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Evaluating the NCCN Clinical Criteria for Recommending <i>BRCA1</i> and <i>BRCA2</i> Genetic Testing in Patients With Breast CancerCaiqian Cropper, Ashley Woodson, Banu Arun, et al.
Cancer|August 7, 2007
Multifocal breast cancer in women < or =35 years oldJennifer K Litton, Yesim Eralp, Ana M Gonzalez-Angulo, et al.
Journal of Adolescent and Young Adult Oncology|August 25, 2020
Impact of a Genetic Evaluation Initiative to Increase Access to Genetic Services for Adolescent and Young Adults at a Tertiary Cancer HospitalSukh Makhnoon, Jessica Corredor, Banu Arun, et al.
Pageof 18